[HTML][HTML] Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast …
A Gornowicz, W Szymanowski… - Oncology …, 2019 - spandidos-publications.com
The aim of the present study was to examine the multi‑targeted potential of a monoclonal
antibody against mucin‑1 (MUC1) and novel octahydropyrazin [2, 1‑a: 5, 4‑a'] diisoquinoline …
antibody against mucin‑1 (MUC1) and novel octahydropyrazin [2, 1‑a: 5, 4‑a'] diisoquinoline …
Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer …
A Gornowicz, W Szymanowski, A Bielawska… - Oncology …, 2019 - europepmc.org
The aim of the present study was to examine the multi-targeted potential of a monoclonal
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a′] …
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a′] …
Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer …
A Gornowicz, W Szymanowski… - Oncology …, 2019 - pubmed.ncbi.nlm.nih.gov
The aim of the present study was to examine the multi‑targeted potential of a monoclonal
antibody against mucin‑1 (MUC1) and novel octahydropyrazin [2, 1‑a: 5, 4‑a'] diisoquinoline …
antibody against mucin‑1 (MUC1) and novel octahydropyrazin [2, 1‑a: 5, 4‑a'] diisoquinoline …
[PDF][PDF] Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast …
A GORNOWICZ, W SZYMANOWSKI… - ONCOLOGY …, 2019 - pdfs.semanticscholar.org
The aim of the present study was to examine the multi-targeted potential of a monoclonal
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a'] diisoquinoline …
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a'] diisoquinoline …
Monoclonal anti-MUC1 antibody with novel octahydropyrazino [2, 1-a: 5, 4-a′] diisoquinoline derivative as a potential multi-targeted strategy in MCF-7 breast cancer …
A Gornowicz, W Szymanowski, A Bielawska… - Oncology …, 2019 - search.proquest.com
The aim of the present study was to examine the multi-targeted potential of a monoclonal
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a′] …
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a′] …
[PDF][PDF] Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast …
A GORNOWICZ, W SZYMANOWSKI… - ONCOLOGY …, 2019 - researchgate.net
The aim of the present study was to examine the multi-targeted potential of a monoclonal
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a'] diisoquinoline …
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a'] diisoquinoline …
Monoclonal anti-MUC1 antibody with novel octahydropyrazino [2, 1-a: 5, 4-a'] diisoquinoline derivative as a potential multi-targeted strategy in MCF-7 breast cancer …
A Gornowicz, W Szymanowski, A Bielawska… - Oncology …, 2019 - go.gale.com
Breast cancer represents the leading cause of death in women worldwide and has a poor
prognosis. Estrogen and estrogen receptors (ERs) play key roles in breast cancer …
prognosis. Estrogen and estrogen receptors (ERs) play key roles in breast cancer …
[HTML][HTML] Monoclonal anti-MUC1 antibody with novel octahydropyrazino [2, 1-a: 5, 4-a′] diisoquinoline derivative as a potential multi-targeted strategy in MCF-7 breast …
A Gornowicz, W Szymanowski, A Bielawska… - Oncology …, 2019 - ncbi.nlm.nih.gov
The aim of the present study was to examine the multi-targeted potential of a monoclonal
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a′] …
antibody against mucin-1 (MUC1) and novel octahydropyrazin [2, 1-a: 5, 4-a′] …
[HTML][HTML] Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast …
A Gornowicz, W Szymanowski… - Oncology …, 2019 - spandidos-publications.com
The aim of the present study was to examine the multi‑targeted potential of a monoclonal
antibody against mucin‑1 (MUC1) and novel octahydropyrazin [2, 1‑a: 5, 4‑a'] diisoquinoline …
antibody against mucin‑1 (MUC1) and novel octahydropyrazin [2, 1‑a: 5, 4‑a'] diisoquinoline …
Monoclonal anti‑MUC1 antibody with novel octahydropyrazino [2, 1‑a: 5, 4‑a'] diisoquinoline derivative as a potential multi‑targeted strategy in MCF‑7 breast cancer …
A GORNOWICZ, W SZYMANOWSKI… - ONCOLOGY …, 2019 - ingentaconnect.com
The aim of the present study was to examine the multitargeted potential of a monoclonal
antibody against mucin1 (MUC1) and novel octahydropyrazin [2, 1a: 5, 4a'] diisoquinoline …
antibody against mucin1 (MUC1) and novel octahydropyrazin [2, 1a: 5, 4a'] diisoquinoline …